Account wins from the 10/21/05 News Brief

Share this article:

Upside Endeavors has been engaged for global publication management and U.S. advocacy development for Wyeth's injectable antibiotic Tygacil (tigecycline).

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions